Perception of chemotherapy side effects cancer versus noncancer patients.
about
Chemotherapy-induced nausea and vomiting: optimizing prevention and managementDiscovering Outliers of Potential Drug Toxicities Using a Large-scale Data-driven ApproachThermoregulatory correlates of nausea in rats and musk shrews.Enhanced and selective delivery of enzyme therapy to 9L-glioma tumor via magnetic targeting of PEG-modified, β-glucosidase-conjugated iron oxide nanoparticles.Self-care strategies to cope with taste changes after chemotherapy.Pulsed electrostatic fields (ETG) to reduce hair loss in women undergoing chemotherapy for breast carcinoma: a pilot study.Treatment of chemotherapy-induced alopecia.Patient preferences for side effects associated with cervical cancer treatmentSynthesis, characterization, and biological activity of poly(arginine)-derived cancer-targeting peptides in HepG2 liver cancer cells.Taste alterations in cancer patients receiving chemotherapy: a neglected side effect?Chemotherapy-related nausea and vomiting - past reflections, present practice and future management.Combination of aprepitant, palonosetron and dexamethasone as antiemetic prophylaxis in lung cancer patients receiving multiple cycles of cisplatin-based chemotherapy.Antiemetic therapy in cancer: an update.Antiemetic efficacy of single-dose palonosetron and dexamethasone in patients receiving multiple cycles of multiple day-based chemotherapyPalonosetron as an anti-emetic and anti-nausea agent in oncology.Patients' experiences of having chemotherapy in a day hospital setting.Treatment options in end-of-life care: the role of palliative chemotherapy.Magnetic targeting of novel heparinized iron oxide nanoparticles evaluated in a 9L-glioma mouse model.Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting.Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.Efficacy and safety of pirarubicin plus capecitabine versus pirarubicin plus cyclophosphamide in Chinese node-negative breast cancer patients: a 4-year open-label, randomized, controlled study.A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy.Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving allogeneic hematopoietic stem cell transplantation.Preference weights for chemotherapy side effects from the perspective of women with breast cancer.Taste alterations in breast and gynaecological cancer patients receiving chemotherapy: prevalence, course of severity, and quality of life correlates.Effectively managing chemotherapy-induced nausea and vomiting.Chemotherapy induced nausea and vomiting: a European perspective.Addition of aprepitant improves protection against cisplatin-induced emesis when a conventional anti-emetic regimen fails.Taste and smell perception and quality of life during and after systemic therapy for breast cancer.Management of Patients With Chemotherapy-Induced Nausea and Vomiting.
P2860
Q26852601-2F42B74A-0596-4E83-91C9-1E707C624F0EQ31140868-FD7A602F-CE00-4FAE-835F-8B94C318B091Q33688928-3B335FEE-AEA2-4F5D-8414-333A12E2E10EQ33769441-9F0141AE-D2D2-4C11-AD0D-B776CDC7FC6CQ33947487-DF985A10-93DE-4069-BFDF-07C055B6A051Q34138227-CF54E682-E407-48F0-B893-C61177D5D351Q34215602-C200E9D4-3BAE-44A8-A1AD-AFE4AC3AA242Q34871388-ECED5C42-360D-418B-8196-0A2886DD93B8Q35188533-F66F894E-6D8A-410D-8D50-CE39C72094F5Q35584199-F15B69D5-DE73-45C5-8F09-D0556C5D7375Q35666500-025F18C7-4EED-4D89-9475-4AF18B92B3D8Q36220364-A295C96E-25B9-4A75-BBDA-F9341B0B6A65Q36222061-335107CB-DB71-4A00-8884-C0E3EEC7C6A4Q36345449-D92B41F7-9ECF-48AF-868F-2CEA898B63F9Q36663660-CDF4F7D1-9CB0-44DA-812C-700CB5CE48B8Q36859228-89ACC86D-2DA4-42AF-9C32-3E58D947F22DQ37029886-0ADBB606-BF46-417F-B083-00FFEF313EE3Q37619920-853EAB7B-5128-455A-8EB6-A8FD35824C90Q38574240-BF54B252-22BC-4470-AD9B-33CF9A80E2F9Q38739169-36F7C5C1-73A7-496C-B277-66045E196400Q40928391-A551E437-5580-46A4-BA18-536E65451C73Q41394455-780A44DD-1556-4F13-852F-BB7C1BEC7F0BQ42728433-45D9C368-1CA6-4A6D-97BC-A63ECFEB2ED3Q43581868-6AA8D1B7-B037-4B92-9E1A-E258D49397D8Q48151443-2595F71B-DA16-421C-8091-B349BD78764EQ48531910-C49942CB-B065-4F38-B438-118E82BF9D85Q48551146-769AC401-4F34-4D8B-8417-935AA3550636Q51560610-85C6B031-F828-4F2C-AA24-86E4F6F92764Q53239014-9F09F403-EACB-4279-AE2E-E739AF4C989BQ55241573-2AD5A22A-20DC-4F52-B0A9-834B22D92863Q55360987-3B781112-9097-40C5-A6A8-FC43EFE60F48
P2860
Perception of chemotherapy side effects cancer versus noncancer patients.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Perception of chemotherapy side effects cancer versus noncancer patients.
@en
Perception of chemotherapy side effects cancer versus noncancer patients.
@nl
type
label
Perception of chemotherapy side effects cancer versus noncancer patients.
@en
Perception of chemotherapy side effects cancer versus noncancer patients.
@nl
prefLabel
Perception of chemotherapy side effects cancer versus noncancer patients.
@en
Perception of chemotherapy side effects cancer versus noncancer patients.
@nl
P2093
P2860
P1433
P1476
Perception of chemotherapy side effects cancer versus noncancer patients.
@en
P2093
P2860
P356
10.1046/J.1523-5394.1999.07205.X
P577
1999-03-01T00:00:00Z